Anti‐hCG Vaccines are in Clinical Trials
- 1 December 1992
- journal article
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 36 (s1) , 123-126
- https://doi.org/10.1111/j.1365-3083.1992.tb01634.x
Abstract
Two vaccines inducing antibodies against human chorionic gonadotropin (hCG) have completed Phase I clinical trials, indicating the reversibility and safety of these vaccines. One is currently in Phase II efficacy trials in women in three major centres in India. The available data suggest that the vaccine prevents pregnancy above antibody titres of 50 ng/ml hCG bioneutralization capacity.Keywords
This publication has 21 references indexed in Scilit:
- Necrosis and Inhibition of Growth of Human Lung Tumor by Anti-α-Human Chorionic Gonadotropin AntibodyJNCI Journal of the National Cancer Institute, 1992
- Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoproteinThe Lancet, 1991
- Antifertility effects of neem ( Azadirachta indica ) oil by single intrauterine administration:a novel method for contraceptionProceedings Of The Royal Society B-Biological Sciences, 1990
- Bioneutralization Capacity of the Antibodies Generated in Women by the Beta Subunit of Human Chorionic Gonadotropin (βhCG) and βhCG Associated with the Alpha Subunit of Ovine Luteinizing Hormone Linked to CarriersAmerican Journal of Reproductive Immunology, 1990
- Bypass by an alternate ‘carrier’ of acquired unresponsiveness to hCG upon repeated immunization with tetanus-conjugated vaccineInternational Immunology, 1990
- Loss of tumorigenic potential by human lung tumor cells in the presence of antisense RNA specific to the ectopically synthesized alpha subunit of human chorionic gonadotropin.The Journal of cell biology, 1989
- Expression of biologically active human chorionic gonadotropin and its subunits by recombinant vaccinia virusGene, 1989
- An improved immunogen for anti-human chorionic gonadotropin vaccine eliciting antibodies reactive with a conformation native to the hormone without cross-reaction with human follicle stimulating hormone and human thyroid stimulating hormoneJournal of Reproductive Immunology, 1988
- Carrier-priming leads to hapten-specific suppressionNature, 1980
- Antibody response to Pr-β-HCG-TT vaccine in human subjectsContraception, 1976